Gene
Entrez ID Entrez Gene ID - the GENE ID in NCBI Gene database.
83872
Gene name Gene Name - the full gene name approved by the HGNC.
Hemicentin 1
Gene symbol Gene Symbol - the official gene symbol approved by the HGNC.
HMCN1
Synonyms (NCBI Gene) Gene synonyms aliases
ARMD1, FBLN6, FIBL-6, FIBL6
Disease Acronyms (UniProt) Disease acronyms from UniProt database
ARMD1
Chromosome Chromosome number
1
Chromosome location Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
1q25.3-q31.1
Summary Summary of gene provided in NCBI Entrez Gene.
This gene encodes a large extracellular member of the immunoglobulin superfamily. A similar protein in C. elegans forms long, fine tracks at specific extracellular sites that are involved in many processes such as stabilization of the germline syncytium,
SNPs SNP information provided by dbSNP.
SNP ID Visualize variation Clinical significance Consequence
rs121434382 A>G Risk-factor Genic downstream transcript variant, missense variant, intron variant, coding sequence variant
rs879255520 C>- Pathogenic Coding sequence variant, frameshift variant
miRNA miRNA information provided by mirtarbase database.
miRTarBase ID miRNA Experiments Reference
MIRT017939 hsa-miR-335-5p Microarray 18185580
MIRT446046 hsa-miR-6805-5p PAR-CLIP 22100165
MIRT446044 hsa-miR-875-3p PAR-CLIP 22100165
MIRT446043 hsa-miR-6128 PAR-CLIP 22100165
MIRT446042 hsa-miR-3179 PAR-CLIP 22100165
Gene ontology (GO) Gene ontology information of associated ontologies with gene provided by GO database.
GO ID Ontology Definition Evidence Reference
GO:0005201 Function Extracellular matrix structural constituent HDA 28344315
GO:0005509 Function Calcium ion binding IEA
GO:0005515 Function Protein binding IPI 19696174
GO:0005604 Component Basement membrane IEA
GO:0005912 Component Adherens junction IBA 21873635
Other IDs Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
MIM HGNC e!Ensembl
608548 19194 ENSG00000143341
Protein
UniProt ID Q96RW7
Protein name Hemicentin-1 (Fibulin-6) (FIBL-6)
Protein function Involved in transforming growth factor beta-mediated rearrangement of the podocyte cytoskeleton which includes reduction of F-actin fibers and broadening, flattening and elongation of podocytes (PubMed:29488390). Plays a role in basement membran
Family and domains

Pfam

Accession ID Position in sequence Description Type
PF07679 I-set 520 608 Immunoglobulin I-set domain Domain
PF07679 I-set 612 697 Immunoglobulin I-set domain Domain
PF07679 I-set 702 789 Immunoglobulin I-set domain Domain
PF07679 I-set 793 884 Immunoglobulin I-set domain Domain
PF13927 Ig_3 889 964 Domain
PF13927 Ig_3 981 1055 Domain
PF07679 I-set 1082 1167 Immunoglobulin I-set domain Domain
PF07679 I-set 1171 1258 Immunoglobulin I-set domain Domain
PF07679 I-set 1272 1355 Immunoglobulin I-set domain Domain
PF07679 I-set 1360 1448 Immunoglobulin I-set domain Domain
PF07679 I-set 1456 1542 Immunoglobulin I-set domain Domain
PF07679 I-set 1551 1635 Immunoglobulin I-set domain Domain
PF07679 I-set 1645 1729 Immunoglobulin I-set domain Domain
PF07679 I-set 1740 1822 Immunoglobulin I-set domain Domain
PF07679 I-set 1829 1915 Immunoglobulin I-set domain Domain
PF07679 I-set 1925 2008 Immunoglobulin I-set domain Domain
PF07679 I-set 2012 2100 Immunoglobulin I-set domain Domain
PF13927 Ig_3 2103 2178 Domain
PF07679 I-set 2200 2286 Immunoglobulin I-set domain Domain
PF07679 I-set 2295 2380 Immunoglobulin I-set domain Domain
PF07679 I-set 2389 2474 Immunoglobulin I-set domain Domain
PF07679 I-set 2480 2567 Immunoglobulin I-set domain Domain
PF07679 I-set 2579 2663 Immunoglobulin I-set domain Domain
PF07679 I-set 2679 2762 Immunoglobulin I-set domain Domain
PF07679 I-set 2784 2865 Immunoglobulin I-set domain Domain
PF07679 I-set 2875 2960 Immunoglobulin I-set domain Domain
PF07679 I-set 2965 3052 Immunoglobulin I-set domain Domain
PF07679 I-set 3062 3147 Immunoglobulin I-set domain Domain
PF13927 Ig_3 3150 3228 Domain
PF07679 I-set 3249 3336 Immunoglobulin I-set domain Domain
PF07679 I-set 3346 3430 Immunoglobulin I-set domain Domain
PF07679 I-set 3437 3523 Immunoglobulin I-set domain Domain
PF13927 Ig_3 3526 3603 Domain
PF07679 I-set 3623 3709 Immunoglobulin I-set domain Domain
PF07679 I-set 3713 3800 Immunoglobulin I-set domain Domain
PF07679 I-set 3804 3893 Immunoglobulin I-set domain Domain
PF13927 Ig_3 3896 3971 Domain
PF13927 Ig_3 3987 4062 Domain
PF07679 I-set 4079 4165 Immunoglobulin I-set domain Domain
PF13927 Ig_3 4168 4243 Domain
PF13927 Ig_3 4260 4332 Domain
PF07679 I-set 4354 4436 Immunoglobulin I-set domain Domain
PF13927 Ig_3 4439 4513 Domain
PF00090 TSP_1 4533 4583 Thrombospondin type 1 domain Domain
PF00090 TSP_1 4590 4640 Thrombospondin type 1 domain Domain
PF00090 TSP_1 4647 4697 Thrombospondin type 1 domain Domain
PF00090 TSP_1 4704 4754 Thrombospondin type 1 domain Domain
PF00090 TSP_1 4761 4811 Thrombospondin type 1 domain Domain
PF00090 TSP_1 4818 4868 Thrombospondin type 1 domain Domain
PF07474 G2F 4870 5052 G2F domain Domain
PF07645 EGF_CA 5147 5190 Calcium-binding EGF domain Domain
PF07645 EGF_CA 5192 5228 Calcium-binding EGF domain Domain
PF07645 EGF_CA 5230 5270 Calcium-binding EGF domain Domain
PF07645 EGF_CA 5272 5313 Calcium-binding EGF domain Domain
PF07645 EGF_CA 5315 5354 Calcium-binding EGF domain Domain
PF12662 cEGF 5452 5475 Complement Clr-like EGF-like Domain
Tissue specificity TISSUE SPECIFICITY: Expressed in hair follicles and in the dermis (at protein level). {ECO:0000269|PubMed:32035013}.; TISSUE SPECIFICITY: [Isoform 1]: Expressed in skin fibroblasts and retinal pigment epithelium (RPE) cells. {ECO:0000269|PubMed:14570714}.
Sequence
MISWEVVHTVFLFALLYSSLAQDASPQSEIRAEEIPEGASTLAFVFDVTGSMYDDLVQVI
EGASKILETSLKRPKRPLFNFALVPFHDPEIGPVTITTDPKKFQYELRELYVQGGGDCPE
MSIGAIKIALEISLPGSFIYVFTDARSKDYRLTHEVLQLIQQKQSQVVFVLTGDCDDRTH
IGYKVYEEIASTSSGQVFHLDKKQVNEVLKWVEEAVQASKVHLLSTDHLEQAVNTWRIPF
DPSLKEVTVSLSGPSPMIEIRNPLGKLIKKGFGLHELLNIHNSAKVVNVKEPEAGMWTVK
TSSSGRHSVRITGLSTIDFRAGFSRKPTLDFKKTVSRPVQGIPTYVLLNTSGISTPARID
LLELLSISGSSLKTIPVKYYPHRKPYGIWNISDFVPPNEAFFLKVTGYDKDDYLFQRVSS
VSFSSIVPDAPKVTMPEKTPGYYLQPGQIPCSVDSLLPFTLSFVRNGVTLGVDQYLKESA
SVNLDIAKVTLSDEGFYECIAVSSAGTGRAQTFFDVSEPPPVIQVPNNVTVTPGERAVLT
CLIISAVDYNLTWQRNDRDVRLAEPARIRTLANLSLELKSVKFNDAGEYHCMVSSEGGSS
AASVFLTV
QEPPKVTVMPKNQSFTGGSEVSIMCSATGYPKPKIAWTVNDMFIVGSHRYRM
TSDGTLFIKNAAPKDAGIYGCLASNSAGTDKQNSTLR
YIEAPKLMVVQSELLVALGDITV
MECKTSGIPPPQVKWFKGDLELRPSTFLIIDPLLGLLKIQETQDLDAGDYTCVAINEAGR
ATGKITLDV
GSPPVFIQEPADVSMEIGSNVTLPCYVQGYPEPTIKWRRLDNMPIFSRPFS
VSSISQLRTGALFILNLWASDKGTYICEAENQFGKIQSETTVTV
TGLVAPLIGISPSVAN
VIEGQQLTLPCTLLAGNPIPERRWIKNSAMLLQNPYITVRSDGSLHIERVQLQDGGEYTC
VASN
VAGTNNKTTSVVVHVLPTIQHGQQILSTIEGIPVTLPCKASGNPKPSVIWSKKGEL
ISTSSAKFSAGADGSLYVVSPGGEESGEYVCTATN
TAGYAKRKVQLTVYVRPRVFGDQRG
LSQDKPVEISVLAGEEVTLPCEVKSLPPPIITWAKETQLISPFSPRHTFLPSGSMKITET
RTSDSGMYLCVATNIAGNVTQAVKLNV
HVPPKIQRGPKHLKVQVGQRVDIPCNAQGTPLP
VITWSKGGSTMLVDGEHHVSNPDGTLSIDQATPSDAGIYTCVATNIAGTDETEITLHV
QE
PPTVEDLEPPYNTTFQERVANQRIEFPCPAKGTPKPTIKWLHNGRELTGREPGISILEDG
TLLVIASVTPYDNGEYICVAVNEAGTTERKYNLKV
HVPPVIKDKEQVTNVSVLLNQLTNL
FCEVEGTPSPIIMWYKDNVQVTESSTIQTVNNGKILKLFRATPEDAGRYSCKAINIAGTS
QKYFNIDV
LVPPTIIGTNFPNEVSVVLNRDVALECQVKGTPFPDIHWFKDGKPLFLGDPN
VELLDRGQVLHLKNARRNDKGRYQCTVSNAAGKQAKDIKLTI
YIPPSIKGGNVTTDISVL
INSLIKLECETRGLPMPAITWYKDGQPIMSSSQALYIDKGQYLHIPRAQVSDSATYTCHV
ANVAGTAEKSFHVDV
YVPPMIEGNLATPLNKQVVIAHSLTLECKAAGNPSPILTWLKDGV
PVKANDNIRIEAGGKKLEIMSAQEIDRGQYICVATSVAGEKEIKYEVDV
LVPPAIEGGDE
TSYFIVMVNNLLELDCHVTGSPPPTIMWLKDGQLIDERDGFKILLNGRKLVIAQAQVSNT
GLYRCMAANTAGDHKKEFEVTV
HVPPTIKSSGLSERVVVKYKPVALQCIANGIPNPSITW
LKDDQPVNTAQGNLKIQSSGRVLQIAKTLLEDAGRYTCVATNAAGETQQHIQLHV
HEPPS
LEDAGKMLNETVLVSNPVQLECKAAGNPVPVITWYKDNRLLSGSTSMTFLNRGQIIDIES
AQISDAGIYKCVAINSAGATELFYSLQV
HVAPSISGSNNMVAVVVNNPVRLECEARGIPA
PSLTWLKDGSPVSSFSNGLQVLSGGRILALTSAQISDTGRYTCVAVNAAGEKQRDIDLRV

YVPPNIMGEEQNVSVLISQAVELLCQSDAIPPPTLTWLKDGHPLLKKPGLSISENRSVLK
IEDAQVQDTGRYTCEATN
VAGKTEKNYNVNIWVPPNIGGSDELTQLTVIEGNLISLLCES
SGIPPPNLIWKKKGSPVLTDSMGRVRILSGGRQLQISIAEKSDAALYSCVASNVAGTAKK
EYNLQV
YIRPTITNSGSHPTEIIVTRGKSISLECEVQGIPPPTVTWMKDGHPLIKAKGVE
ILDEGHILQLKNIHVSDTGRYVCVAVNVAGMTDKKYDLSV
HAPPSIIGNHRSPENISVVE
KNSVSLTCEASGIPLPSITWFKDGWPVSLSNSVRILSGGRMLRLMQTTMEDAGQYTCVVR
NAAGEERKIFGLSV
LVPPHIVGENTLEDVKVKEKQSVTLTCEVTGNPVPEITWHKDGQPL
QEDEAHHIISGGRFLQITNVQVPHTGRYTCLASSPAGHKSRSFSLNV
FVSPTIAGVGSDG
NPEDVTVILNSPTSLVCEAYSYPPATITWFKDGTPLESNRNIRILPGGRTLQILNAQEDN
AGRYSCVATNEAGEMIKHYEVKV
YIPPIINKGDLWGPGLSPKEVKIKVNNTLTLECEAYA
IPSASLSWYKDGQPLKSDDHVNIAANGHTLQIKEAQISDTGRYTCVASNIAGEDELDFDV
NI
QVPPSFQKLWEIGNMLDTGRNGEAKDVIINNPISLYCETNAAPPPTLTWYKDGHPLTS
SDKVLILPGGRVLQIPRAKVEDAGRYTCVAVNEAGEDSLQYDVRV
LVPPIIKGANSDLPE
EVTVLVNKSALIECLSSGSPAPRNSWQKDGQPLLEDDHHKFLSNGRILQILNTQITDIGR
YVCVAENTAGSAKKYFNLNV
HVPPSVIGPKSENLTVVVNNFISLTCEVSGFPPPDLSWLK
NEQPIKLNTNTLIVPGGRTLQIIRAKVSDGGEYTCIAINQAGESKKKFSLTV
YVPPSIKD
HDSESLSVVNVREGTSVSLECESNAVPPPVITWYKNGRMITESTHVEILADGQMLHIKKA
EVSDTGQYVCRAINVAGRDDKNFHLNV
YVPPSIEGPEREVIVETISNPVTLTCDATGIPP
PTIAWLKNHKRIENSDSLEVRILSGGSKLQIARSQHSDSGNYTCIASN
MEGKAQKYYFLS
IQVPPSVAGAEIPSDVSVLLGENVELVCNANGIPTPLIQWLKDGKPIASGETERIRVSAN
GSTLNIYGALTSDTGKYTCVATNPAGEEDRIFNLNV
YVTPTIRGNKDEAEKLMTLVDTSI
NIECRATGTPPPQINWLKNGLPLPLSSHIRLLAAGQVIRIVRAQVSDVAVYTCVASNRAG
VDNKHYNLQV
FAPPNMDNSMGTEEITVLKGSSTSMACITDGTPAPSMAWLRDGQPLGLDA
HLTVSTHGMVLQLLKAETEDSGKYTCIASNEAGEVSKHFILKV
LEPPHINGSEEHEEISV
IVNNPLELTCIASGIPAPKMTWMKDGRPLPQTDQVQTLGGGEVLRISTAQVEDTGRYTCL
ASS
PAGDDDKEYLVRVHVPPNIAGTDEPRDITVLRNRQVTLECKSDAVPPPVITWLRNGE
RLQATPRVRILSGGRYLQINNADLGDTANYTCVASNIAGKTTREFILTV
NVPPNIKGGPQ
SLVILLNKSTVLECIAEGVPTPRITWRKDGAVLAGNHARYSILENGFLHIQSAHVTDTGR
YLCMATNAAGTDRRRIDLQV
HVPPSIAPGPTNMTVIVNVQTTLACEATGIPKPSINWRKN
GHLLNVDQNQNSYRLLSSGSLVIISPSVDDTATYECTVTNGAGDDKRTVDLTV
QVPPSIA
DEPTDFLVTKHAPAVITCTASGVPFPSIHWTKNGIRLLPRGDGYRILSSGAIEILATQLN
HAGRYTCVARN
AAGSAHRHVTLHVHEPPVIQPQPSELHVILNNPILLPCEATGTPSPFIT
WQKEGINVNTSGRNHAVLPSGGLQISRAVREDAGTYMCVAQN
PAGTALGKIKLNVQVPPV
ISPHLKEYVIAVDKPITLSCEADGLPPPDITWHKDGRAIVESIRQRVLSSGSLQIAFVQP
GDAGHYTCMAANVAGSSSTSTKLTV
HVPPRIRSTEGHYTVNENSQAILPCVADGIPTPAI
NWKKDNVLLANLLGKYTAEPYGELILENVVLEDSGFYTCVANN
AAGEDTHTVSLTVHVLP
TFTELPGDVSLNKGEQLRLSCKATGIPLPKLTWTFNNNIIPAHFDSVNGHSELVIERVSK
EDSGTYVCTAEN
SVGFVKAIGFVYVKEPPVFKGDYPSNWIEPLGGNAILNCEVKGDPTPT
IQWNRKGVDIEISHRIRQLGNGSLAIYGTVNEDAGDYTCVATNEAGVVERSMSLTL
QSPP
IITLEPVETVINAGGKIILNCQATGEPQPTITWSRQGHSISWDDRVNVLSNNSLYIADAQ
KEDTSEFECVARN
LMGSVLVRVPVIVQVHGGFSQWSAWRACSVTCGKGIQKRSRLCNQPL
PANGGKPCQGSDLEMRNCQNKPC
PVDGSWSEWSLWEECTRSCGRGNQTRTRTCNNPSVQH
GGRPCEGNAVEIIMCNIRPC
PVHGAWSAWQPWGTCSESCGKGTQTRARLCNNPPPAFGGS
YCDGAETQMQVCNERNC
PIHGKWATWASWSACSVSCGGGARQRTRGCSDPVPQYGGRKCE
GSDVQSDFCNSDPC
PTHGNWSPWSGWGTCSRTCNGGQMRRYRTCDNPPPSNGGRACGGPD
SQIQRCNTDMC
PVDGSWGSWHSWSQCSASCGGGEKTRKRLCDHPVPVKGGRPCPGDTTQV
TRCNVQAC
PGGPQRARGSVIGNINDVEFGIAFLNATITDSPNSDTRIIRAKITNVPRSLG
SAMRKIVSILNPIYWTTAKEIGEAVNGFTLTNAVFKRETQVEFATGEILQMSHIARGLDS
DGSLLLDIVVSGYVLQLQSPAEVTVKDYTEDYIQTGPGQLYAYSTRLFTIDGISIPYTWN
HTVFYDQAQGRM
PFLVETLHASSVESDYNQIEETLGFKIHASISKGDRSNQCPSGFTLDS
VGPFCADEDECAAGNPCSHSCHNAMGTYYCSCPKGLTIAADGRTCQDIDECALGRHTCHA
GQDCDNTIGSYRCVVRCGSGFRRTSDGLSC
QDINECQESSPCHQRCFNAIGSFHCGCEPG
YQLKGRKC
MDVNECRQNVCRPDQHCKNTRGGYKCIDLCPNGMTKAENGTCIDIDECKDGT
HQCRYNQICENTRGSYRCVCPRGYRSQGVGRPC
MDINECEQVPKPCAHQCSNTPGSFKCI
CPPGQHLLGDGKSC
AGLERLPNYGTQYSSYNLARFSPVRNNYQPQQHYRQYSHLYSSYSE
YRNSRTSLSRTRRTIRKTCPEGSEASHDTCVDIDECENTDACQHECKNTFGSYQCICPPG
YQLTHNGKTCQDIDE
CLEQNVHCGPNRMCFNMRGSYQCIDTPCPPNYQRDPVSGFCLKNC
PPNDLECALSPYALEYKLVSLPFGIATNQDLIRLVAYTQDGVMHPRTTFLMVDEEQTVPF
ALRDENLKGVVYTTRPLREAETYRMRVRASSYSANGTIEYQTTFIVYIAVSAYPY
Sequence length 5635
Interactions View interactions
Associated diseases Disease information provided by ClinVar, GenCC, and GWAS databases.
Causal
Disease term Disease name dbSNP ID References
Cholelithiasis Cholelithiasis rs121918440, rs72552778, rs387906528, rs759202962, rs377160065, rs1051861187, rs757693457, rs752563752 17632509
Age-related macular degeneration Age related macular degeneration, Macular Degeneration, Age-Related, 1, NON RARE IN EUROPE: Age-related macular degeneration rs199474657, rs61750120, rs1800728, rs62654397, rs61749423, rs61751412, rs61749439, rs61751398, rs61752417, rs62645946, rs1801269, rs62646860, rs61750142, rs61750145, rs61750152
View all (20 more)
14570714
Unknown
Disease term Disease name Evidence References Source
Astrocytoma Astrocytoma GWAS
Oligodendroglioma Oligodendroglioma GWAS
Glioblastoma Glioblastoma CRISPR screening of E3 ubiquitin ligases reveals Ring Finger Protein 185 as a novel tumor suppressor in glioblastoma repressed by promoter hypermethylation and miR-587 GWAS, CBGDA
Associations from Text Mining
Disease Name Relationship Type References
Adenocarcinoma Associate 30720096
Breast Neoplasms Associate 34888385, 39684297
Carcinoma Renal Cell Associate 35886066
Diabetic Nephropathies Associate 20299368
Epidermolysis Bullosa Simplex Associate 39976599
Fibroma Associate 26121316
Macular Degeneration Associate 14691731, 15467524, 16885922, 17057786, 31635417, 31792352
Multiple Myeloma Associate 26545722
Neoplasms Associate 30720096, 35886066
Ovarian Neoplasms Associate 35735060